Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “progesterone”

32 pharma patents match "progesterone" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 32
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 32 pharmaceutical patents matching "progesterone" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

32 results for “progesterone” · 30,257 patents in full index Clear search

  1. US 6566372

    Bicyclic androgen and progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted May 20, 2003 · Expires May 15, 2023

    expired
  2. US 6509334

    Cyclocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Jan 21, 2003 · Expires Jan 16, 2023

    expired
  3. US 6444668

    Combination regimens using progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Sep 3, 2002 · Expires Aug 29, 2022

    expired
  4. US 6436929

    Cyclothiocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Aug 20, 2002 · Expires Aug 15, 2022

    expired
  5. US 6358947

    Tetracyclic progesterone receptor modulator compounds and methods

    Ligand Pharmaceuticals Incorporated · Granted Mar 19, 2002 · Expires Mar 14, 2022

    expired
  6. US 6358948

    Quinazolinone and benzoxazine derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Mar 19, 2002 · Expires Mar 14, 2022

    expired
  7. US 6040340

    Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors

    The Board of Regents, Univ. of Texas System · Granted Mar 21, 2000 · Expires Mar 16, 2020

    expired
  8. US 6028106

    Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents

    Board of Regents, The Univ. of TX System · Granted Feb 22, 2000 · Expires Feb 17, 2020

    expired